Yıl: 2006 Cilt: 21 Sayı: 1 Sayfa Aralığı: 18 - 22 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity

Öz:
Amaç: Reaktif Oksijen Ürünleri (ROS), romatoid artrit (RA) gibi akut ve kronik inflamatuvar olaylarda önemli rol oynamaktadırlar. Bu çalışma RA'li hastalardaki ROS ve antioksidan etkinin varlığını araştırmak amacıyla planlandı. Hastalar ve Yöntem: Antioksidan etkinlik total protein sülfidril (SH) düzeyi ile, ROS ise protein karbonil ve malondialdehid (MDA) düzeyleri ile belirlendi. Çalışmaya yaşları 31-68 arasında toplam 29 RA'li hasta alındı. Kontrol grubu aynı cins ve yaşta 20 sağlıklı bireyden oluşturuldu. Hasta ve kontrol grubunun serumlarından total protein SH, protein karbonil ve MDA düzeyleri ölçüldü. Bulgular: RA'li hastalarda total protein SH düzeylerinde kontrol grubuna göre belirgin azalma olduğu gözlendi (396.26±42.33 mmol/L vs 677.21±59.98 mmol/L, p<0.001). Ayrıca sırasıyla protein karbonil ve MDA düzeylerinde de kontrol grubuna göre istatistiksel anlamlı artış olduğu tespit edildi (105.45±14.26 mmol/L vs 93.65±10.49 mmol/L, p<0.05, 14.51±2.28 mmol/L vs 5.56±1.25 mmol/L, p<0.001). Hastalık aktivasyonu olanlarda remisyondakilere göre daha yüksek MDA düzeyleri ve daha düşük protein SH değerleri olduğu görüldü. RA'li hastalarda protein karbonil düzeyleri ve eritrosit sedimentasyon hızı (ESR) ve C-reaktif Protein (CRP) düzeyleri arasında negatif bir korelasyon (r=-0.415, p<0.05, r=-0.687, p<0.001) saptandı. Aktif hastalığı olanlarda herhangi bir ilişki bulunmamasına rağmen remisyondaki hastalarda protein karbonil ve ESR ve CRP arasında negatif bir korelasyon tespit edildi. Sonuç: Sonuç olarak RA'da ROS ‘de artış görülmektedir ve bu biyokimyasal belirteçlerin ölçümü ile inflamasyon düzeyi hakkında bilgi edinilebilinir.
Anahtar Kelime: Malondialdehit Reaktif oksijen türleri Artrit, romatoid Lipid peroksidasyonu

Konular: Romatoloji

Romatoid artrit'li hastaların, serum protein sülfidril, protein karbonil ve lipid peroksidasyon düzeylerindeki değişim: Hastalık aktivasyonu ile ilişkisi

Öz:
Objective: Reactive Oxygen Species (ROS) play a major role in the generation of acute and chronic inflammatory processes one of which is rheumatoid arthritis (RA). Patients and Methods: This study was designed to investigate ROS and antioxidant affects in RA patients. The antioxidant activity was determined by measuring total protein sulfhydryl (SH) levels. ROS was indicated by measuring protein carbonyls and malondialdehyde (MDA) levels. A total of 29 RA patients aged between 31 to 68 years old were recruited. Also 20 control subjects were selected from healthy individuals Total protein SH, protein carbonyls and MDA levels were measured from sera of both groups. Results: Total protein SH levels of RA patients were found to be significantly decreased than those found in control group (396,26±42,33 mmol/L vs 677,21±59,98 mmol/L, p<0,001). Also the levels of protein carbonyls and MDA were found to be statistically increased in RA patients respectively (105,45±14,26 mmol/L vs 93,65±10,49 mmol/L, p<0,05, 14,51±2,28 mmol/L vs 5,56±1,25 mmol/L, p<0,001). Patients active in disease had higher levels of MDA and lower levels of total protein SH levels when compared to those patients in remission. A negative correlation was found between protein carbonyls and erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) (r=-0,415, p<0,05, r=-0,687, p<0,001) in RA patients. No correlation was found in patients active in disease but negative corelation was found between protein carbonyls and ESR and CRP in patients in remission. Conclusion: In conclusion the level of ROS seems to increase and measurement of these markers may give us information about inflammatory process in RA.
Anahtar Kelime: Malondialdehyde Reactive Oxygen Species Arthritis, Rheumatoid Lipid Peroxidation

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Alarcon GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 1995; 21: 589-604.
  • 2. Merry P, Winyard PG, Morris CJ, Grootveld M, Blake DR. Oxygen free radicals, inflammation, and synovitis: the current status. Ann Rheum Dis 1989; 48: 864-70.
  • 3. Halliwell B. Oxygen radicals and human disease. Ann Intern Med 1987; 107: 526-45.
  • 4. Schenck P, Schneider S, Miehlke R, Prehm P. Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis. J Rheumatol 1995; 22: 400-5.
  • 5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism association 1987 revised criteria for the classification of RA. Arthritis Rheum 1988; 31: 315-24.
  • 6. Fuch HA, Brooks RH, Callahan LF, Pincus T. A simplified twenty-eight joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 1989; 32: 531-7.
  • 7. Koster JF, Biemond P, Swaak, AJ. Intracellular and extracellular sulfhydryl levels in rheumatoid arthritis. Ann Rheum Dis 1986; 45: 44-6.
  • 8. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-78.
  • 9. Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
  • 10. Simonini G, Matucci CM, Cimaz R, Anichini M, Cesaretti S, Zoppi M, et al. Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis. J Rheumatol 2001; 28: 198-203.
  • 11. Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol 2001; 21: 69-73.
  • 12. Schett G, Tohidast-Akrad M, Steiner G, Smolen J. The stressed synovium. Arthritis Res 2001; 3: 80-6.
  • 13. Mazzetti I, Grigolo B, Pulsatelli L, Dolzani P, Silvestri T, Rosetti L, et al. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci 2001; 101: 593-9.
  • 14. Amara A, Constans J, Chaugier C, Sebban A, Dubourg L, Peuchant E, et al. Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitis. Clin Exp Immunol 1995; 101: 233-8.
  • 15. Mapp PI, Grootveld MC, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 51: 419-36.
  • 16. Zamamiri-Davis F, Lu Y, Thompson JT, Prabhu KS, Reddy PV, Sordillo LM, et al. Nuclear factor kappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 2002; 32: 890-7.
  • 17. Del Carlo M, Loeser RF. Nitric oxide mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 2002; 46: 394-403.
  • 18. Ostrakhovitch EA, Afanas'ev IB. Oxidative stress in rheumatoid arthritis leucocytes: suppression by rutin and other antioxidants and chelators. Biochem Pharmacol 2001; 62: 743-6.
  • 19. Taraza C, Mohora M, Vargolici B, Dinu V. Importance of reactive oxygen species in rheumatoid arthritis. Rom J Intern Med 1997; 35: 89-98.
  • 20. Janiszewski M, Gaweda J, Drzewoski J. Concentration of serum sulphydryl groups in patients with rheumatoid arthritis. Wiad Lek 1994; 47: 654-8.
  • 21. Miesel R, Zuber M. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatoid diseases. Inflammation 1993; 17: 551-61.
  • 22. Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002; 21: 200-4.
  • 23. Mulherin DM, Thurnham DI, Situnayake RD. Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. Ann Rheum Dis 1996; 55: 837-40.
  • 24. Rojkovich B, Nagy E, Prohle T, Poor G, Gergely P. Urinary excretion of thiol compounds in patients with rheumatoid arthritis. Clin Diagn Lab Immunol 1999; 6: 683-5.
  • 25. Mantle D, Falkous G, Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chem Acta 1999; 284: 45-58.
  • 26. Chapman ML, Rubin BR, Gracy RW. Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1989; 16: 15-8.
  • 27. Renke J, Popadiuk S, Korzon M, Bugajczyk B, Wozniak M. Protein carbonyl groups' contents as a useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Radic Biol Med 2000; 29: 101-4.
  • 28. Cimen MY, Cimen OB, Kacmaz M, Ozturk HS, Yorgancioglu R, Durak I. Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 2000; 19: 275-7.
  • 29. Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999; 19: 35-7.
  • 30. Chaturvedi V, Handa R, Rao DN, Wali JP. Estimation & significance of serum & synovial fluid malondialdehyde levels in rheumatoid arthritis. Indian J Med Res 1999; 109: 170-4.
  • 31. Kiziltunc A, Cogalgil S, Cerragoglu L. Carnitine and antioxidants levels in patients with rheumatoid arthritis. Scand J Rheumatol 1998; 27: 441-5.
  • 32. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 1997; 30: 351-5.
  • 33. Sklodowska M, Gromadzinska J, Biernacka M, Wasowicz W, Wolkanin P, Marszalek A, Brozik H, Pokuszynska K. Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clin Exp Rheumatol 1996; 14: 433-9.
  • 34. Wade CR, Jackson PG, Highton J, van Rij AM. Lipid peroxidation and malondialdehyde in the synovial fluid and plasma of patients with rheumatoid arthritis. Clin Chim Acta 1987; 164: 245-50.
  • 35. Kajanachumpol S, Vanichapuntu M, Verasertniyom O, Totemchokchyakarn K, Vatanasuk M. Levels of plasma lipid peroxide products and antioxidant status in rheumatoid arthritis. Southeast Asian J Trop Med Public Health 200; 31: 335-8.
APA Serteser M, Evcik F, KÖKEN T, KAHRAMAN A (2006). Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. , 18 - 22.
Chicago Serteser Mustafa,Evcik Fatma Deniz,KÖKEN Tülay,KAHRAMAN AHMET Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. (2006): 18 - 22.
MLA Serteser Mustafa,Evcik Fatma Deniz,KÖKEN Tülay,KAHRAMAN AHMET Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. , 2006, ss.18 - 22.
AMA Serteser M,Evcik F,KÖKEN T,KAHRAMAN A Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. . 2006; 18 - 22.
Vancouver Serteser M,Evcik F,KÖKEN T,KAHRAMAN A Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. . 2006; 18 - 22.
IEEE Serteser M,Evcik F,KÖKEN T,KAHRAMAN A "Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity." , ss.18 - 22, 2006.
ISNAD Serteser, Mustafa vd. "Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity". (2006), 18-22.
APA Serteser M, Evcik F, KÖKEN T, KAHRAMAN A (2006). Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. Romatizma Dergisi , 21(1), 18 - 22.
Chicago Serteser Mustafa,Evcik Fatma Deniz,KÖKEN Tülay,KAHRAMAN AHMET Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. Romatizma Dergisi 21, no.1 (2006): 18 - 22.
MLA Serteser Mustafa,Evcik Fatma Deniz,KÖKEN Tülay,KAHRAMAN AHMET Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. Romatizma Dergisi , vol.21, no.1, 2006, ss.18 - 22.
AMA Serteser M,Evcik F,KÖKEN T,KAHRAMAN A Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. Romatizma Dergisi . 2006; 21(1): 18 - 22.
Vancouver Serteser M,Evcik F,KÖKEN T,KAHRAMAN A Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity. Romatizma Dergisi . 2006; 21(1): 18 - 22.
IEEE Serteser M,Evcik F,KÖKEN T,KAHRAMAN A "Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity." Romatizma Dergisi , 21, ss.18 - 22, 2006.
ISNAD Serteser, Mustafa vd. "Changes in protein sulfhydryls, protein carbonyls and lipid peroxidation levels in sera of patients with rheumatoid arthritis: Correlation with disease activity". Romatizma Dergisi 21/1 (2006), 18-22.